CARDINAL HEALTH INC

DE+I issues including the Equality Act.

Drug Supply Chain Security Act (DSCSA); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Drug Shortage Prevention and Mitigation Act; Supply chain issues and delays related to US borders and ports; Issues related to the medical supply chain and transportation bottlenecks.

Fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); the National Defense Authorization Act (H.R. 8070); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.

Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.

Issues related to tax reform and 2017 Tax Cuts and Jobs Act.